| 15h00 – 16h10 | CU 01 Clinical Update | |
| Chairs: S. Kasper (Austria) – S. Montgomery (UK) | ||
| 15h00 – 15h25 | CU 0101 Which brain stimulation method has the best evidence base in resistant depression? Frank Padberg (Germany) |
|
| Discussion 10 minutes | ||
| 15h35 – 16h00 | CU 0102 Are antidepressants effective in depression in schizophrenia or Alzheimer’s? Hans-Jürgen Möller (Germany) |
|
| Discussion 10 minutes | ||
| 16h15 – 17h25 | CU 02 Clinical Update 2 | |
| Chairs: H.J. Möller (Germany) – J. Raboch ( Czech Republic) | ||
| 16h15 – 16h40 | CU 0201 The evidence base for the efficacy of CBT in MDD Borwin Bandelow (Germany) |
|
| Discussion 10 minutes | ||
| 16h50 – 17h15 | CU 0202 Is the neuropsychiatric classification of psychotropics helpful to clinicians? Joseph Zohar (Israel) |
|
| Discussion 10 minutes | ||
| 17h30 – 17h50 | Prevalence and current practice in treatment of depression in Czech Republic | |
| Chairs: S. Kasper (Austria) – S. Montgomery (UK) | ||
| Jiri Raboch (Czech Republic) | ||
| 17h50 – 18h15 | CU 03 Clinical Update 3 SURVEY | |
| Chairs: S. Kasper (Austria) – S. Montgomery (UK) | ||
| Discussion on the on line Survey | ||
| 18h15 – 19h15 | Opening reception |
| 08h30 – 09h40 | CU 04 Clinical Update 4 | |
| Chairs: D. Baldwin (UK) – J. Zohar (Israel) | ||
| 08h30 – 08h55 | CU 0401 Advances in the treatment of OCD and related disorders Naomi Fineberg (UK) |
|
| Discussion 10 minutes | ||
| 09h05 – 09h30 | CU 0402 New findings in the treatment of anxiety disorders Borwin Bandelow (Germany) |
|
| Discussion 10 minutes | ||
| 09h40 – 10h45 | CU 05 Clinical Update5 | |
| Chairs: E. Vieta (Spain) – J. Raboch (Czech Republic) | ||
| 09h40 – 10h05 | CU 0501 Treating comorbid alcohol abuse in depression David Baldwin (UK) |
|
| 10h05 – 10h30 | CU 0502 Clinical update on the pharmacological management of alcohol use disorders Julia Sinclair (UK) |
|
| Discussion 15 minutes | ||
| 10h45 – 11h00 | Coffee Break | |
| 11h00 – 12h10 | CU 06 Clinical Update 6 | |
| Chairs: J. Sinclair (UK) – B. Bandelow (Germany) | ||
| 11h00 – 11h25 | CU 0601 Update on treating resistant bipolar depression Eduard Vieta (Spain) |
|
| 11h25 – 11h50 | CU 0602 Treating bipolar disorder in the presence of comorbidity Allan Young (UK) |
|
| Discussion 20 minutes | ||
| 12h10 – 12h45 | Lecture: Smoking or Quitting: which is best for neuropsychiatric patients | |
| Chair: S. Montgomery (UK) | ||
| Henri-Jean Aubin (France) | ||
| Discussion 15 minutes | ||
| 13h00 – 14h30 | Strolling Poster Award Session & Lunch | |
| 14h30 – 16h30 | SO 01 International Society for Affective Disorders (ISAD) Symposium |
|
| Chair: A. Young (UK) | ||
| 14h30 – 14h55 | Advances in the treatment and understanding of Depression S0 0101 Brain Catecholamines and Reward Processing in Major Depression Gregor Hasler (Switzerland) |
|
| 15h00 – 15h25 | S0 0102 Forging a New Path: Innovative Treatments for Unmet Needs in Depression Mohammad Alsuwaidan (Kuwait) |
|
| 15h30 – 15h55 | S0 0103 British Association for Psychopharmacology, Treatment Guidelines in Depression 2015: An Update on the Evidence Anthony Cleare (UK) |
|
| 16h00 – 16h25 | S0 0104 Vulnerability for recurrence in MDD; mechanisms, underlying brain dysfunction and potential targets for prevention Henricus Ruhé (The Netherlands) |
|
| ➤ Please note that 5 questions will be allowed at the end of each session | ||
| 16h30 – 17h00 | Coffee break | |
| 17h00 – 18h15 | SS 01 Scientific Session 1 | |
| Chairs: A. Young (UK) – G. Hasler (Switzerland) | ||
| 17h00 – 17h25 | SS 0101 Concomitant antidepressant and antipsychotic medication in schizophrenia and depression. Role of prefrontal glutamatergic mechanisms Torgny Svensson (Sweden) |
|
| Discussion 10 minutes | ||
| 17h35 – 18h00 | SS 0102 Mood food: Gut issues in depression and anxiety Ted Dinan (Ireland) |
|
| Discussion 10 minutes |
| 09h00 – 10h10 | CU 07 Clinical Update 7 | |
| Chairs: A. Serretti (Italy) – T. Dinan (Ireland) | ||
| 09h00 – 09h25 | CU 0701 Pluses and minuses of DSM5 in depression and anxiety disorders Stefano Pallanti (Italy) |
|
| Discussion 10 minutes | ||
| 09h35 – 10h00 | CU 0702 What do post hoc analyses of antidepressant trials tell us regarding true efficacy and safety? Elias Eriksson (Sweden) |
|
| Discussion 10 minutes | ||
| 10h15 – 11h50 | SO Symposium 02 | |
| Chairs: S. Montgomery (UK) – S. Pallanti (Italy) | ||
| 10h15 – 10h40 | SO 0201 Markers and personalised medicine in depression and anxiety Alessandro Serretti (Italy) |
|
| Discussion 10 minutes | ||
| 10h50 – 11h15 | SO 0202 Management of treatment nonresponse and treatment resistant depression Stuart Montgomery (UK) |
|
| Discussion 10 minutes | ||
| 11h25 – 11h50 | SO 0203 The meta-analysis of lifetime comorbidity: bipolar and anxiety disorders Behrouz Nabavi (UK) |
|
| Discussion 10 minutes | ||
| 12h00 – 12h15 | Closing remarks & Farewell coffee |